Expanding our Understanding of Atypical Antipsychotics: Acute Urinary Retention Secondary to Olanzapine
Antipsychotics are considered the most efficacious drugs in the treatment of schizophrenia and other psychotic disorders. While clinicians monitor for the onset of extrapyramidal symptoms (EPSs), many do not consider the antimuscarinic and histaminergic side effects that can occur with second genera...
| Published in: | Case Reports in Psychiatry |
|---|---|
| Main Authors: | Hannah Mirzakhani, Mariam Rahim, Jacob Mathew |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Online Access: | http://dx.doi.org/10.1155/2020/6157548 |
Similar Items
Olanzapine-Associated Chronic Urinary Retention and Ciliochoroidal Effusion: Rare Adverse Effects of a Commonly Prescribed Antipsychotic
by: Abhiram Narasimhan Purohith, et al.
Published: (2023-01-01)
by: Abhiram Narasimhan Purohith, et al.
Published: (2023-01-01)
Antipsychotic olanzapine-induced misfolding of proinsulin in the endoplasmic reticulum accounts for atypical development of diabetes
by: Satoshi Ninagawa, et al.
Published: (2020-11-01)
by: Satoshi Ninagawa, et al.
Published: (2020-11-01)
Atypical Antipsychotic Drug Olanzapine Deregulates Hepatic Lipid Metabolism and Aortic Inflammation and Aggravates Atherosclerosis
by: Chia-Hui Chen, et al.
Published: (2018-10-01)
by: Chia-Hui Chen, et al.
Published: (2018-10-01)
An economic model to understand the cost-effectiveness of olanzapine orally dispersible tablets (ODT) and olanzapine film coated tablets as a group compared with other oral atypical antipsychotics for treating schizophrenia in Morocco
by: Ahmed Tazi, et al.
Published: (2024-09-01)
by: Ahmed Tazi, et al.
Published: (2024-09-01)
Modulation of hemispheric asymmetry in executive control of attention in schizophrenia with atypical antipsychotic treatment: Potential benefits of olanzapine
by: Yong Zhao, et al.
Published: (2024-06-01)
by: Yong Zhao, et al.
Published: (2024-06-01)
Acute Urinary Retention Associated with Olanzapine Long-acting Injection: A Case Report
by: Astut Kurariya, et al.
Published: (2024-05-01)
by: Astut Kurariya, et al.
Published: (2024-05-01)
Atypical antipsychotics:
by: Claudia Aparecida Avelar Ferreira, et al.
Published: (2015-10-01)
by: Claudia Aparecida Avelar Ferreira, et al.
Published: (2015-10-01)
The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse.
by: Andrew P Morgan, et al.
Published: (2014-01-01)
by: Andrew P Morgan, et al.
Published: (2014-01-01)
Hyponatremia secondary to acute urinary retention
by: Jignesh Parikh, et al.
Published: (2017-01-01)
by: Jignesh Parikh, et al.
Published: (2017-01-01)
Membrane Permeability Monitoring to Antipsychotic Olanzapine Using Platinum Black-Modified Electrodes
by: Murugaiya Sridar Ilango, et al.
Published: (2025-04-01)
by: Murugaiya Sridar Ilango, et al.
Published: (2025-04-01)
Comparative Evaluation of Typical Antipsychotic Haloperidol with Atypical Antipsychotics Olanzapine, Risperidone and Aripiprazole in the Treatment of Stable Schizophrenia in a Tertiary Care Teaching Hospital at Dehradun, Uttarakhand, India: A Randomised Clinical Trial
by: Subhash Vishal Garg, et al.
Published: (2025-04-01)
by: Subhash Vishal Garg, et al.
Published: (2025-04-01)
Atypical antipsychotics in the treatment of schizophrenia
by: Swiss Medical Weekly
Published: (2003-02-01)
by: Swiss Medical Weekly
Published: (2003-02-01)
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
by: Correll Christoph, et al.
Published: (2005-05-01)
by: Correll Christoph, et al.
Published: (2005-05-01)
Labial Adhesion with Acute Urinary Retention Secondary to Vaginitis
by: Şenol Şentürk, et al.
Published: (2014-01-01)
by: Şenol Şentürk, et al.
Published: (2014-01-01)
Tunable Intranasal Polymersome Nanocarriers Triggered Olanzapine Brain Delivery and Improved In Vivo Antipsychotic Activity
by: Ahmed A. Katamesh, et al.
Published: (2025-06-01)
by: Ahmed A. Katamesh, et al.
Published: (2025-06-01)
Pharmaco-epidemiological description of the population of the Marche Region (central Italy) treated with the antipsychotic drug olanzapine
by: Fiorenzo Mignini, et al.
Published: (2013-03-01)
by: Fiorenzo Mignini, et al.
Published: (2013-03-01)
Constrictive Pericarditis Associated with Atypical Antipsychotics
by: Kuan-chin Jean Chen, et al.
Published: (2012-01-01)
by: Kuan-chin Jean Chen, et al.
Published: (2012-01-01)
Anti-stress Properties of Atypical Antipsychotics
by: Alice Sanson, et al.
Published: (2020-10-01)
by: Alice Sanson, et al.
Published: (2020-10-01)
Atypical Antipsychotics Induced Metabolic Syndrome
by: Aysegul Demirel, et al.
Published: (2015-03-01)
by: Aysegul Demirel, et al.
Published: (2015-03-01)
Predictors of effect of atypical antipsychotics on speech
by: Preeti Sinha, et al.
Published: (2015-01-01)
by: Preeti Sinha, et al.
Published: (2015-01-01)
Methamphetamine psychosis, the efficacy of atypical antipsychotics
by: Amir Rezaei Ardani, et al.
Published: (2015-01-01)
by: Amir Rezaei Ardani, et al.
Published: (2015-01-01)
New atypical antipsychotics for schizophrenia: iloperidone
by: Silvio Caccia, et al.
Published: (2010-02-01)
by: Silvio Caccia, et al.
Published: (2010-02-01)
An unusual complication of a long-acting injectable antipsychotic: deep venous thrombosis caused by olanzapine pamoate
by: Serhat Tunç, et al.
Published: (2018-04-01)
by: Serhat Tunç, et al.
Published: (2018-04-01)
Central retinal vein occlusion in a patient using the antipsychotic drug olanzapine: a case report
by: Ali Nowrouzi, et al.
Published: (2021-05-01)
by: Ali Nowrouzi, et al.
Published: (2021-05-01)
Predictors of antipsychotic monotherapy with olanzapine during a 1-year naturalistic study of schizophrenia patients in Japan
by: Ye W, et al.
Published: (2012-01-01)
by: Ye W, et al.
Published: (2012-01-01)
Olanzapine as a Cause of Urinary Incontinence: A Case Report
by: Mobolaji Usman Dada, et al.
Published: (2012-09-01)
by: Mobolaji Usman Dada, et al.
Published: (2012-09-01)
Olanzapine as a cause of urinary incontinence: a case report.
by: Mobolaji Usman Dada, et al.
Published: (2012-09-01)
by: Mobolaji Usman Dada, et al.
Published: (2012-09-01)
Expanding our understanding of the trade in marine aquarium animals
by: Andrew L. Rhyne, et al.
Published: (2017-01-01)
by: Andrew L. Rhyne, et al.
Published: (2017-01-01)
COST AND EFFECTIVENESS OF ATYPICAL-ATYPICAL ANTIPSYCHOTIC COMBINATIONS AND ATYPICAL-TYPICAL ANTIPSYCHOTIC COMBINATIONS IN PATIENTS OF PSYCHOTIC DISORDERS IN INSTALLATION OF EMERGENCY IN GRHASIA MENTAL HOSPITAL, YOGYAKARTA
by: Arya Dibyo Adisaputra, et al.
Published: (2021-11-01)
by: Arya Dibyo Adisaputra, et al.
Published: (2021-11-01)
Screening benzimidazole derivatives for atypical antipsychotic activity
by: K. Yu. Kalitin, et al.
Published: (2025-08-01)
by: K. Yu. Kalitin, et al.
Published: (2025-08-01)
Use of atypical antipsychotics in individuals with anorexia nervosa
by: Danielle L. Stutzman, PharmD, BCPP
Published: (2025-02-01)
by: Danielle L. Stutzman, PharmD, BCPP
Published: (2025-02-01)
Therapeutic drug monitoring of atypical antipsychotic drugs
by: Grundmann Milan, et al.
Published: (2014-12-01)
by: Grundmann Milan, et al.
Published: (2014-12-01)
Can atypical antipsychotic drugs cause hepatotoxicity?
by: R. André, et al.
Published: (2021-04-01)
by: R. André, et al.
Published: (2021-04-01)
Clozapine: A special case of an atypical antipsychotic
by: Elina Marinho
Published: (2024-04-01)
by: Elina Marinho
Published: (2024-04-01)
Hematological Side Effects of Atypical Antipsychotic Drugs
by: Serap Erdogan
Published: (2009-10-01)
by: Serap Erdogan
Published: (2009-10-01)
Evidence for Therapeutic Drug Monitoring of Atypical Antipsychotics
by: Veronika Krejčí, et al.
Published: (2024-05-01)
by: Veronika Krejčí, et al.
Published: (2024-05-01)
Clinical considerations in selecting and using atypical antipsychotics
by: Haupt Dan
Published: (2006-02-01)
by: Haupt Dan
Published: (2006-02-01)
Effect of atypical antipsychotics on glucose and lipid metabolism
by: Madoka Fujimaki, et al.
Published: (2012-01-01)
by: Madoka Fujimaki, et al.
Published: (2012-01-01)
Atypical Antipsychotics and the Human Skeletal Muscle Lipidome
by: Kyle J. Burghardt, et al.
Published: (2018-10-01)
by: Kyle J. Burghardt, et al.
Published: (2018-10-01)
Atypical antipsychotics as augmentation therapy in anorexia nervosa.
by: Enrica Marzola, et al.
Published: (2015-01-01)
by: Enrica Marzola, et al.
Published: (2015-01-01)
Similar Items
-
Olanzapine-Associated Chronic Urinary Retention and Ciliochoroidal Effusion: Rare Adverse Effects of a Commonly Prescribed Antipsychotic
by: Abhiram Narasimhan Purohith, et al.
Published: (2023-01-01) -
Antipsychotic olanzapine-induced misfolding of proinsulin in the endoplasmic reticulum accounts for atypical development of diabetes
by: Satoshi Ninagawa, et al.
Published: (2020-11-01) -
Atypical Antipsychotic Drug Olanzapine Deregulates Hepatic Lipid Metabolism and Aortic Inflammation and Aggravates Atherosclerosis
by: Chia-Hui Chen, et al.
Published: (2018-10-01) -
An economic model to understand the cost-effectiveness of olanzapine orally dispersible tablets (ODT) and olanzapine film coated tablets as a group compared with other oral atypical antipsychotics for treating schizophrenia in Morocco
by: Ahmed Tazi, et al.
Published: (2024-09-01) -
Modulation of hemispheric asymmetry in executive control of attention in schizophrenia with atypical antipsychotic treatment: Potential benefits of olanzapine
by: Yong Zhao, et al.
Published: (2024-06-01)
